V8Y — Quantum Healthcare Income Statement
0.000.00%
Last trade - 00:00- SG$16.03m
- SG$22.63m
- SG$13.08m
Annual income statement for Quantum Healthcare, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
R2022 December 31st | 2023 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PRESS | PRESS |
| Standards: | — | — |
| Status: | Final | Final |
| Revenue | ||
| Total Revenue | 9.37 | 13.1 |
| Cost of Revenue | ||
| Gross Profit | 4.35 | 5.76 |
| Selling / General / Administrative Expenses | ||
| Research And Development | ||
| Unusual Expense / Income | ||
| Other Operating Expenses | ||
| Total Operating Expenses | 17.8 | 16 |
| Operating Profit | -8.47 | -2.93 |
| Total Net Non Operating Interest Income / Expense | ||
| Net Income Before Taxes | -8.92 | -3.42 |
| Provision for Income Taxes | ||
| Net Income After Taxes | -9.03 | -3.52 |
| Minority Interest | ||
| Net Income Before Extraordinary Items | ||
| Net Income | -9.2 | -3.76 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Diluted Net Income | -9.2 | -3.76 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | -0.001 | -0.001 |